GlassScriptPhysician profile
James T Jerzak
NPI 1760466502
$690.25
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513 · 2020: $177.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $190.59 | 2019-2020 | |
| Amgen INC. | $58.46 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $49.81 | 2020 | |
| Allergan, INC. | $45.41 | 2019-2020 | |
| Glaxosmithkline, LLC. | $40.93 | 2019-2020 | |
| Shire North American Group INC | $40.48 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $39.94 | 2019-2020 | |
| Roche Diagnostics Corporation | $37.94 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.26 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $29.21 | 2020 | |
| Scilex Pharmaceuticals INC. | $18.40 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.53 | 2019 | |
| Supernus Pharmaceuticals, INC. | $16.70 | 2019 | |
| Neurocrine Biosciences, INC. | $12.40 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.13 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $11.68 | 2019 | |
| Alexion Pharmaceuticals, INC. | $11.33 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $10.97 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.08 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Jerzak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.